Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01851395 · ClinicalTrials.gov registry record
Rapid Autopsy and Procurement of Cancer Tissue
A clinical trial of Mesothelioma and Lung Cancers, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 275
- Enrollment target
- 1
- Study location
NCT01851395: Recruiting study of Mesothelioma and Lung Cancers, sponsored by National Cancer Institute (NCI).
NCT01851395 is a study of Mesothelioma and Lung Cancers that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 275 participants, above the 192-participant average among 46 other Mesothelioma trials with a reported enrollment target (43% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01851395, a study of Mesothelioma and Lung Cancers, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 275 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Individuals with cancer of the lung, chest cavity, ovary, or bladder, as well as patients who have been treated with adoptive cell therapy unfortunately commonly succumb to their disease. Some agree to donate their bodies to cancer research that may help the medical community better understand these diseases. Studies of cancer tumor tissue obtained soon after death may be used to answer questions about the origins, progression, and treatment of cancer. Researchers want to conduct a study that involves planned collection of cancer tumor tissue shortly after death. To do so, they will arrange to provide inpatient hospice care for people with lung cancer, ovarian cancer, bladder cancer, or patients who have been treated with adoptive cell therapy. \<TAB\> Objectives: \- To collect cancer tissue biopsy samples as soon as possible after death. Eligibility: \- Individuals who have cancer of the lung, chest cavity, ovary, or bladder, or those who have been treated with adoptive cell therapy and are planning to receive end-of-life hospice care are eligible to participate. Design: * Participants will agree to receive inpatient hospice care at the National Institutes of Health Clinical Center. Full details on end-of-life care preference will be acknowledged. * An autopsy will be performed at the clinical center within 3 hours of death. Tumor tissue will be collected from the primary site of cancer and from any areas of the body to which the cancer has spread. * Participants will not receive further cancer treatments as part of this study. This is a tissue collection study only.
Primary Outcome
Both intratumor and between paired primary and metastatic site, using integrated genomic and proteomic analysis.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2013-12-30 |
What NCT01851395 shows while recruiting
NCT01851395 is an observational study that tracks outcomes without assigning an intervention. The registered 275 participants enrollment target is mid-sized for trials with a published cap, above the 192-participant average among 46 other Mesothelioma trials with a reported enrollment target (43% higher).
The record links to 5 conditions, with Mesothelioma appearing as the primary indexed condition, and to 0 interventions.
NCT01851395 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01851395 about?
NCT01851395 is a clinical study titled "Rapid Autopsy and Procurement of Cancer Tissue". Background: \- Individuals with cancer of the lung, chest cavity, ovary, or bladder, as well as patients who have been treated with adoptive cell therapy unfortunately commonly succumb to their disease. Some agree to donate their bodies to cancer research that may help the medical community better ...
What is the current status of trial NCT01851395?
This trial is currently recruiting. The enrollment target is 275 participants. The study started on 2013-12-30.
What conditions does trial NCT01851395 study?
This clinical trial studies the following conditions: Mesothelioma, Lung Cancers, Thymus Tumors, Adoptive Cellular Therapy, Genitourinary Cancers.
Who is sponsoring clinical trial NCT01851395?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01851395 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mesothelioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01851395's enrollment target sits among peer trials
275 10th of 46 higher than 37 of 46 other Mesothelioma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mesothelioma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Sacituzumab Govitecan in People With Mesothelioma
RECRUITING · Phase 2
-
Olaparib in Patients With HRD Malignant Mesothelioma
RECRUITING · Phase 2
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
RECRUITING
-
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
RECRUITING · Phase 1
-
Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269190 · 275 participants · NA
Wide-Field and High Resolution In Vivo Imaging in Visualizing Lesions in Patients With Oral Neoplasia Undergoing Surgery
- NCT01900132 · 275 participants · NA
Electrical Impedance Myography: Natural History Studies inNeuromuscular Disorders and Healthy Volunteers
- NCT04104776 · 275 participants · Phase 1
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- NCT04765150 · 275 participants
Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI